文献速递乳房整形与再造

乳房再造中组织扩张器与永久植入物放疗时机对患者报告结局的影响:多中心前瞻性研究

Patient-Reported Outcomes after Irradiation of Tissue Expander versus Permanent Implant in Breast Reconstruction: A Multicenter Prospective Study.
PubMed 文献 · Plast Reconstr Surg · 2020-01-01

该多中心前瞻性研究纳入317例即刻两阶段扩张器/植入物再造并接受乳房切除术后放疗的患者,比较交换前(237例)与交换后(80例)放疗对并发症和患者报告结局的影响。结果显示放疗时机对总体并发症、重大并发症及再造失败风险无显著影响,对大多数患者报告结局也无显著影响,但交换后放疗组焦虑、疲劳和抑郁较少。

要点

  • 放疗时机对并发症风险无显著影响:总体并发症OR 1.25(p=0.46),重大并发症OR 1.18(p=0.62),再造失败OR 0.72(p=0.49)。
  • 放疗时机对BREAST-Q和EORTC调查的2年患者报告结局无显著影响。
  • 交换后放疗组PROMIS显示焦虑、疲劳和抑郁较少,但差异可能无临床意义。

核心结论

  • 放疗时机(交换前或交换后)对即刻扩张器/植入物再造的并发症风险及大多数患者报告结局无显著影响。
  • 交换后放疗组焦虑、抑郁和疲劳较低,但可能无临床意义。

研究设计与样本

  • 多中心前瞻性研究,纳入11个Mastectomy Reconstruction Outcomes Consortium sites的317例即刻扩张器/植入物再造并接受乳房切除术后放疗的患者。
  • 237例在扩张器/植入物交换前接受放疗(before-exchange cohort),80例在交换后接受放疗(after-exchange cohort)。
  • 使用BREAST-Q、PROMIS和EORTC Breast Cancer-Specific Quality-of-Life Questionnaire在术前和术后2年评估患者报告结局,采用双变量比较和多变量回归分析。

主要发现

  • 放疗时机对总体并发症风险无显著影响(OR 1.25;p=0.46)。
  • 放疗时机对重大并发症风险无显著影响(OR 1.18;p=0.62)。
  • 放疗时机对再造失败风险无显著影响(OR 0.72;p=0.49)。
  • 放疗时机对BREAST-Q或EORTC调查测量的2年患者报告结局无显著影响。
  • PROMIS测量显示交换后放疗组焦虑、疲劳和抑郁较少。

临床怎么用

  • 对于即刻两阶段扩张器/植入物再造需放疗的患者,交换前或交换后放疗对并发症和大多数患者报告结局影响相似,决策可个体化。

局限性

  • 交换后放疗组PROMIS显示的焦虑、抑郁和疲劳差异可能无临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Whether to irradiate the tissue expander before implant exchange or to defer irradiation until after exchange in immediate, two-stage expander/implant reconstruction remains uncertain. The authors evaluated the effects of irradiation timing on complication rates and patient-reported outcomes in patients undergoing immediate expander/implant reconstruction. METHODS: Immediate expander/implant reconstruction patients undergoing postmastectomy radiation therapy at 11 Mastectomy Reconstruction Outcomes Consortium sites with demographic, clinical, and complication data were analyzed. Patient-reported outcomes were assessed with BREAST-Q, Patient-Reported Outcomes Measurement Information System, and European Organisation for Research and Treatment of Cancer Breast Cancer-Specific Quality-of-Life Questionnaire surveys preoperatively and 2 years postoperatively. Survey scores and complication rates were analyzed using bivariate comparison and multivariable regressions. RESULTS: Of 317 patients who met inclusion criteria, 237 underwent postmastectomy radiation therapy before expander/implant exchange (before-exchange cohort), and 80 did so after exchange (after-exchange cohort). Timing of radiation had no significant effect on risks of overall complications (OR, 1.25; p = 0.46), major complications (OR, 1.18; p = 0.62), or reconstructive failure (OR, 0.72; p = 0.49). Similarly, radiation timing had no significant effect on 2-year patient-reported outcomes measured by the BREAST-Q or the European Organisation for Research and Treatment of Cancer survey. Outcomes measured by the Patient-Reported Outcomes Measurement Information System showed less anxiety, fatigue, and depression in the after-exchange group. Compared with preoperative assessments, 2-year patient-reported outcomes significantly declined in both cohorts for Satisfaction with Breasts, Physical Well-Being, and Sexual Well-Being, but improved for anxiety and depression. CONCLUSIONS: Radiation timing (before or after exchange) had no significant effect on complication risks or on most patient-reported outcomes in immediate expander/implant reconstruction. Although lower levels of anxiety, depression, and fatigue were observed in the after-exchange group, these differences may not be clinically significant. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Yoon AP, Qi J, Kim HM, et al. Patient-Reported Outcomes after Irradiation of Tissue Expander versus Permanent Implant in Breast Reconstruction: A Multicenter Prospective Study. Plast Reconstr Surg. 2020. PMID: 32332528. doi:10.1097/PRS.0000000000006724

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。